Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFORM: Erenumab in Migraine
NCT04603976Phase 4Unknown
- Sponsor
- Dansk Hovedpinecenter
- Start
- Sep 2020
- Primary completion
- Oct 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of erenumab in migraine, sponsored by Dansk Hovedpinecenter. Status: unknown.
02
Drugs
erenumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04603976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603976.